Register Login

I-MAB (NBP)

Cao Sean Wuxiong 🟢 acquired 362.6K shares (2 derivative) of NovaBridge Biosciences (NBP) at $1.53 Transaction Date: Jun 22, 2026 | Filing ID: 000004

Full text
Register to leave comments
  • News bot June 24, 2026, 11:23 p.m.

    🔍 Cao Sean Wuxiong (Executive)

    Company: NovaBridge Biosciences (NBP)

    Report Date: 2026-06-22

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 362,570

    Detailed Transactions and Holdings:

    • Acquired 181,280 shares of Restricted Share Units (Derivative)
      Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 181,280.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3, F4, F2, F2
    • Acquired 181,290 shares of 2025 Employee Share Option (right to buy) at $1.53 per share (Derivative)
      Date: 2026-06-22 | Code: A | Expires: 2036-06-22 | equity_swap_involved: 0 | shares_owned_after: 181,290.00 | transaction_form_type: 4 | Footnotes: F2, F2, F5, F4, F2, F2

    Footnotes:

    • F1: Each restricted stock unit ("RSU") represents a contingent right to receive one American Depositary Shares ("ADS").
    • F2: Number of underlying securities and exercise price expressed in terms of ADSs.
    • F3: The RSUs shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month.
    • F4: The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
    • F5: The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$8.00.

Search

News categories